Clinical trial

Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture Method

NCT02025413

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-11-01

PhaseNA

Study timeline

Study start (unknown)2011-11-01Date precision: month

Registry last updated2018-12-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Progressive Castration-resistant Prostate Cancerunresolved

Metastatic Progressive Breast Cancerunresolved

Interventions

Mesenchymal-marker based ferrofluid (N-cadherin or O-cadherin based)DEVICE

Sponsors & collaborators

Duke Universitylead sponsor

Prostate Cancer Foundationcollaborator

United States Department of Defensecollaborator

Janssen Diagnostics, LLCcollaborator

Mapped research locations

DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02025413 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.